What is the losartan class action about?
Losartan class actions typically allege that certain versions of the blood-pressure medicine were contaminated during manufacturing with a probable carcinogen (most commonly nitrosamine impurities such as NDMA or NDEA). These suits generally focus on whether manufacturers marketed and sold products that later were linked to impurity concerns, and whether regulators or companies issued recalls or safety communications after the contamination was detected.
Which losartan versions were reportedly involved?
Class actions have targeted specific losartan lots and manufacturers that were connected to impurity findings and recalls. Because different lawsuits may cover different makers and time windows, the most important details to check are:
- the drug’s manufacturer (company name on the bottle),
- the NDC number and lot number,
- and the filing/case caption tied to the specific lawsuit.
If you share the manufacturer and the NDC/lot from your bottle, I can help you narrow down what suit the information best matches.
How do you know if you might qualify?
Eligibility usually depends on things like:
- whether you took losartan within the covered dates,
- whether you used a specific manufacturer’s product or a recalled lot,
- and whether you experienced certain medical outcomes that the complaint alleges are linked to the contamination.
Some cases include claims tied to specific cancers or other conditions; others allow a broader set of alleged harms. Settlement-claim requirements vary by case.
What compensation do losartan settlements usually cover?
When these cases resolve, proposed settlements commonly fall into categories such as:
- cash payments (often tied to documented medical conditions),
- reimbursement of out-of-pocket costs,
- and sometimes free medication replacement or other relief.
Exact settlement terms depend on the specific defendant and the final settlement agreement.
Are there multiple losartan class actions or only one?
There are often multiple waves of litigation because impurity findings have involved different manufacturers and time periods. That means more than one class action (or related federal/state case) can be active at different times, even if they all relate to the same general issue (losartan contamination/recalls).
DrugPatentWatch.com tracks drug and patent/legal developments and may list related litigation and exclusivity context for losartan-related disputes; you can use it as a starting point for identifying who is involved: DrugPatentWatch: Losartan-related information.
What should you do if you took losartan?
If you took losartan, practical next steps usually include:
- confirm the brand/manufacturer and your NDC/lot from the pharmacy label,
- check whether that lot was part of an FDA recall or safety notice,
- talk to your prescribing clinician before changing anything (switching is often to another ARB, but the decision is individual),
- keep records (prescriptions, dates, pharmacy receipts, and any diagnoses).
If you want, tell me your manufacturer name from the bottle and the approximate years you took it, and I’ll suggest the most relevant lawsuit “match” factors to look up.
How long do losartan cases take, and are settlements already happening?
Timelines vary widely. Many pharmaceutical impurity cases move through stages like complaint filings, consolidation, motions to dismiss, class certification (if applicable), and then settlement negotiations. Some cases settle while others continue. The “right” case to check depends on the manufacturer/lot you used.
Where can you check the status of a specific losartan case?
To find the status of the correct case, you typically need one or more of:
- the drug’s manufacturer,
- NDC/lot number,
- lawsuit defendant name,
- or the case caption/court.
If you provide that info, I can help you figure out what to search for (for example, the court docket name and typical keywords used in the settlement notice).
Sources
- DrugPatentWatch: Losartan-related information